AI技术为驱动，生成新颖PTPN2/N1抑制剂 (IMAGE)

InSilico Medicine

AI技术为驱动，生成新颖PTPN2/N1抑制剂

Caption

与参考化合物相比，英矽智能的候选分子展现了更强的体内吸收和口服生物利用度，以及同等生物活性。

Credit

英矽智能

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.